Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome

Journal of the Neurological Sciences

Volumn 298, Issue 1-2, 2010, Pages 106-109

  Yamanaka, Gaku ^a   Kawashima, Hisashi ^a   Oana, Shingo ^a   Ishida, Yu ^a   Miyajima, Tasuku ^a   Kashiwagi, Yasuyo ^a   Hoshika, Akinori ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

ACTH; Cytokine; Epilepsy; Infantile spasm; Interleukin 1 receptor antagonist; West syndrome

Indexed keywords

CORTICOTROPIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL FEATURE; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; HUMORAL IMMUNITY; INFANT; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; WEST SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; SPASMS, INFANTILE;

EID: 77958153097     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.07.018     Document Type: Article

References (23)

1. A. Vezzani, M. Conti, A. De Luigi, T. Ravizza, D. Moneta, and F. Marchesi Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures J Neurosci 19 1999 5054 5065
2. A. Vezzani, D. Moneta, M. Conti, C. Richichi, T. Ravizza, and A. De Luigi Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice Proc Natl Acad Sci USA 97 2000 11534 11539
3. G. Yamanaka, C. Ishii, H. Kawashima, S. Oana, T. Miyajima, and A. Hoshika Cerebrospinal fluid diacron-reactive oxygen metabolite levels in pediatric patients with central nervous system diseases Pediatr Neurol 39 2008 80 84
4. T. Ravizza, S.M. Lucas, S. Balosso, L. Bernardino, G. Ku, and F. Noe Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy Epilepsia 47 2006 1160 1168
5. T. Ravizza, F. Noe, D. Zardoni, V. Vaghi, M. Sifringer, and A. Vezzani Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production Neurobiol Dis 31 2008 327 333
6. J. Peltola, J. Palmio, L. Korhonen, J. Suhonen, A. Miettinen, and M. Hurme Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures Epilepsy Res 41 2000 205 211
7. K.A. Lehtimaki, T. Keranen, J. Palmio, R. Makinen, M. Hurme, and J. Honkaniemi Increased plasma levels of cytokines after seizures in localization-related epilepsy Acta Neurol Scand 116 2007 226 230
8. K. Lehtimaki, T. Keranen, M. Huuhka, J. Palmio, M. Hurme, and E. Leinonen Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder J ECT 24 2008 88 91
9. K.A. Lehtimaki, T. Keranen, J. Palmio, and J. Peltola Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures Neuroimmunomodulation 17 2010 19 22
10. T. Ravizza, K. Boer, S. Redeker, W.G. Spliet, P.C. van Rijen, and D. Troost The IL-1beta system in epilepsy-associated malformations of cortical development Neurobiol Dis 24 2006 128 143
11. T. Ravizza, B. Gagliardi, F. Noe, K. Boer, E. Aronica, and A. Vezzani Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy Neurobiol Dis 29 2008 142 160
12. Z.S. Liu, Q.W. Wang, F.L. Wang, and L.Z. Yang Serum cytokine levels are altered in patients with West syndrome Brain Dev 23 2001 548 551
13. T.C. Montelli, A.M. Soares, and M.T. Peracoli Immunologic aspects of West syndrome and evidence of plasma inhibitory effects on T cell function Arq Neuropsiquiatr 61 2003 731 737
14. H. Tekgul, M. Polat, A. Tosun, G. Serdaroglu, N. Kutukculer, and S. Gokben Cerebrospinal fluid interleukin-6 levels in patients with West syndrome Brain Dev 28 2006 19 23
15. K. Haginoya, R. Noguchi, Y. Zhao, M. Munakata, H. Yokoyama, and S. Tanaka Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome Epilepsy Res 85 2009 314 317
16. Shiihara T, Miyashita M, Yoshizumi M, Watanabe M, Yamada Y, Kato M. Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome. Brain Dev 2009. Epub 2009 Dec 1.
17. T. Ohya, T. Nagai, Y. Araki, T. Yanagawa, T. Tanabe, and K. Iyoda A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome Brain Dev 31 2009 739 743
18. C.T. Lombroso A prospective study of infantile spasms: clinical and therapeutic correlations Epilepsia 24 1983 135 158
19. T. Iwasaki, Y. Nonoda, and M. Ishii Remission associated with human herpesvirus infection in west syndrome J Child Neurol 21 2006 886 890
20. T. Alapirtti, S. Rinta, J. Hulkkonen, R. Makinen, T. Keranen, and J. Peltola Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study J Neurol Sci 280 2009 94 97
21. P. Aukrust, S.S. Froland, N.B. Liabakk, F. Muller, I. Nordoy, and C. Haug Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo Blood 84 1994 2136 2143
22. A.R. Crow, S. Song, J.W. Semple, J. Freedman, and A.H. Lazarus A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 109 2007 155 158
23. D. Kovalovsky, M.P. Pereda, G.K. Stalla, F. Holsboer, and E. Arzt Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and beta-endorphin Neuroimmunomodulation 6 1999 367 372